Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe
  • Home
  • 手術腫瘍学
Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer
Posted innews Oncology Otorhinolaryngology

Determinants of Circulating Tumor HPV DNA in Surgically Treated Oropharyngeal Cancer

Posted by MedXY By MedXY 04/11/2026
This study identifies clinicopathologic factors linked to pre- and postoperative levels of circulating tumor HPV DNA (ctHPVDNA) in HPV-mediated oropharyngeal cancer patients treated with upfront surgery, offering insights for disease monitoring and clinical trial design.
Read More
Redefining Success in Neoadjuvant Therapy for Pancreatic Cancer: The Prognostic Significance of Major Pathologic Response
Posted inClinical Updates news Oncology

Redefining Success in Neoadjuvant Therapy for Pancreatic Cancer: The Prognostic Significance of Major Pathologic Response

Posted by MedXY By MedXY 03/23/2026
This review evaluates the prognostic value of Major Pathologic Response (MPR) in pancreatic ductal adenocarcinoma, analyzing its impact on survival and its potential to guide personalized adjuvant treatment strategies.
Read More
Beyond One-Size-Fits-All: Histologic Subtyping Redefines the Value of Lymph Node Dissection in Early Lung Adenocarcinoma
Posted innews Oncology Respiratory

Beyond One-Size-Fits-All: Histologic Subtyping Redefines the Value of Lymph Node Dissection in Early Lung Adenocarcinoma

Posted by MedXY By MedXY 03/21/2026
A large-scale multicenter study reveals that guideline-adherent lymph node dissection provides a survival benefit only for patients with high-grade lung adenocarcinoma, suggesting that surgical extent should be tailored to histologic subtyping even in early-stage T1N0M0 disease.
Read More
The Socio-Clinical Impact of Medicaid Expansion on Pancreatic Cancer Survival: Evidence from a Multi-State Longitudinal Analysis
Posted inClinical Updates news Oncology

The Socio-Clinical Impact of Medicaid Expansion on Pancreatic Cancer Survival: Evidence from a Multi-State Longitudinal Analysis

Posted by MedXY By MedXY 03/18/2026
This review synthesizes findings on how Medicaid expansion timing influenced surgical resection rates and 2-year mortality for pancreatic cancer, revealing significant survival benefits alongside persistent socioeconomic disparities.
Read More
Laparoscopic Repeated Pancreatectomy: Breaking the Re-operation Barrier with Safety and Precision
Posted inGastroenterology General Surgery news

Laparoscopic Repeated Pancreatectomy: Breaking the Re-operation Barrier with Safety and Precision

Posted by MedXY By MedXY 03/13/2026
A monocentric study of 72 cases demonstrates that laparoscopic repeated pancreatectomy is as safe and effective as the open approach, offering potential benefits in blood loss and venous preservation in high-volume centers.
Read More
Surgical Management of Sporadic Medullary Thyroid Cancer: Evidence-Based Comparison of Total Thyroidectomy vs Lobectomy
Posted inClinical Updates news Oncology Otorhinolaryngology

Surgical Management of Sporadic Medullary Thyroid Cancer: Evidence-Based Comparison of Total Thyroidectomy vs Lobectomy

Posted by MedXY By MedXY 02/27/2026
This systematic review and meta-analysis suggests that thyroid lobectomy may offer comparable oncologic outcomes to total thyroidectomy for selected patients with sporadic medullary thyroid cancer, while significantly reducing postoperative complications.
Read More
  • Delayed Surgery in Bowel Obstruction: A Hidden Driver of Mortality and Recurrence in France
  • From 19 to 2: How a Simplified DNA Test Could Revolutionize Endometrial Cancer Detection
  • Most Women Have Anterior-Apical Prolapse, But Phenotype Does Not Predict Recurrence After Native Tissue Repair
  • Longer Wait, Higher Risk? How Timing of Hypertensive Disorder Diagnosis Shapes Women’s Cardiovascular Future
  • Perioperative Nivolumab Combined with Irreversible Electroporation Shows Antitumoral Effect in High-Risk BCLC A Hepatocellular Carcinoma: Results from the NIVOLEP Phase 2 Trial
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号

  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care depression diabetes epidemiology health heart failure Hypertension immunotherapy inflammation MASLD mental health metformin Mortality multiple myeloma myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prevention prostate cancer public health randomized clinical trial randomized trial SGLT2 inhibitors stroke targeted therapy type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top
Sign in